Investors have been optimistic about coronavirus containment for two weeks now, with stock prices on the rise. Now, with new information coming from clinical trials of experimental drug remdesivir, investor confidence continues to rise. Though more data is needed, the drug appears to successfully treat a high percentage of those with moderate to severe coronavirus symptoms.
Image via Unsplash/Edu Lauton